• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Inari Medical

Inari Medical to bring in up to $186.3M in stock offering

March 11, 2022 By Sean Whooley

Inari Medical (Nasdaq:NARI) announced that it priced an underwritten public offering worth up to $186.3 million in proceeds. Irvine, California-based Inari Medical’s offering includes 2 million shares of its common stock at a public offering price of $81 per share before underwriting discounts and commissions. In addition, the company granted the underwriters a 30-day option […]

Filed Under: Business/Financial News, Catheters, Featured, Funding Roundup, News Well, Vascular Tagged With: Inari Medical

Inari Medical to raise $156m in upsized IPO

May 22, 2020 By Sean Whooley

Inari Medical (NSDQ:NARI) announced that it upsized its initial public offering of common stock shares for total gross proceeds of approximately $156 million. Earlier this week, the venous disease treatment developer announced that it launched the roadshow for its initial public offering (IPO) of shares of its common stock, planning to offer more than 7.3 million […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Vascular, Wall Street Beat Tagged With: Inari Medical, Securities & Exchange Commission (SEC)

Inari Medical plans to launch IPO to raise more than $110m

May 18, 2020 By Sean Whooley

Inari Medical announced today that it launched the roadshow for its initial public offering (IPO) of shares of its common stock. The venous disease treatment developer is offering more than 7.3 million shares of common stock with an expected additional 30-day option for underwriters to purchase close to 1.1 million more shares. Irvine, Calif.-based Inari […]

Filed Under: Business/Financial News, Catheters, Funding Roundup, Initial Public Offering (IPO), Vascular, Wall Street Beat Tagged With: Inari Medical

Cutera snags Vyaire Medical’s Mowry for CEO | Personnel Moves, July 9, 2019

July 9, 2019 By Brad Perriello

Cutera (NSDQ:CUTR) said today that it snagged Vyaire Medical CEO David Mowry to be its new CEO, effective immediately. The aesthetic device maker in January fired president & CEO James Reinstein after the company missed expectations for its 2018 top line, naming COO Jason Richey as interim chief executive. Mowry led Tornier to a $3.3 billion […]

Filed Under: Business/Financial News Tagged With: Camstent, Cerner Corp., Cutera Inc., Dentsply Sirona, Inari Medical, Medline Industries Inc., Neuronetics, Ocular Therapeutix, Personnel Moves, Pfizer, Pure Bioscience

Inari begins ClotTriever outcome study

September 27, 2018 By Nancy Crotti

Inari Medical said it has enrolled the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using its ClotTriever thrombectomy system. The ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature via access sites as small as 6 mm. CLOUT is a 500-patient prospective, multicenter, single-arm registry to evaluate real-world […]

Filed Under: Research & Development, Vascular Tagged With: Inari Medical

Inari Medical wins FDA 510(k) for FlowTriever

May 22, 2018 By Fink Densford

Inari Medical said today it won FDA 510(k) clearance for its FlowTriever stent retriever designed to treat pulmonary embolisms. The clearance came based upon results from the company’s Flare clinical study of the device, which examined data from 106 patients with acute pulmonary embolisms treated with the FlowTriever at 18 US sites, the Irvine, Calif.-based company […]

Filed Under: 510(k), Regulatory/Compliance, Vascular Tagged With: Inari Medical

Inari Medical touts FlowTriever pulmonary embolism study data

April 30, 2018 By Fink Densford

Inari Medical today presented results from a study of its FlowTriever retrieval and aspiration system designed to treat pulmonary embolism, touting the safety and efficacy of the system. Results were presented by Dr. Thomas Tu of Louisville, Ky.’s Baptist Health in San Diego at the Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, […]

Filed Under: Clinical Trials, Vascular Tagged With: Inari Medical

Inari Medical raises $27m

March 29, 2018 By Fink Densford

Inari Medical said today it closed a $27 million Series C round of financing, with funds slated to support commercialization of its FlowTriever and ClotTriever catheters designed for the treatment of venous thromboembolisms. Irvine, Calif.-based Inari’s ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature, while it’s FlowTriever device is […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Inari Medical

Inari Medical wins FDA nod for ClotTriever peripheral thrombectomy device

April 10, 2017 By Brad Perriello

Inari Medical said today that the FDA granted pre-market approval in February for its ClotTriever thrombectomy device Feb. 16 and already has the 1st commercial procedure under its belt. Irvine, Calif.-based Inari said the ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature. The company also makes the FlowTriever device, which […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Inari Medical, Peripheral

FDA approves trial for Inari Medical’s clot-busting FlowTriever

March 8, 2016 By Brad Perriello

Inari Medical said today that it won an investigational device exemption from the FDA for a clinical trial of its FlowTriever device, which is designed to retrieve pulmonary embolisms. Irvine, Calif.-based Inari said it expects to begin enrollment in the 150-patient Flare trial in the coming weeks. The primary safety endpoint is major adverse events within 48 hours, […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: Inari Medical

Inari Medical raises $6m

December 30, 2015 By Fink Densford

Inari Medical today released information on a new $6.1 million equity funding round to support its business and thrombectomy system, according to an SEC filing. Inari produces the FlowTriever thrombectomy system, which is an FDA approved catheter-based thrombectomy device designed to remove clots in the peripheral vasculature, Inari Medical said. The device won FDA 510(k) […]

Filed Under: Business/Financial News Tagged With: Inari Medical

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS